What is it about?
This review highlights how biotic and abiotic environmental stresses—such as drought, salinity, heat, and cold—trigger protective defense mechanisms in medicinal plants, leading to significant fluctuations in their secondary metabolite profiles (as seen in the altered alkaloid and terpene levels of species like Catharanthus roseus, Salvia officinalis, and Papaver somniferum). To address these impacts, the study discusses innovative preservation strategies and genomic tools aimed at protecting vulnerable plant species, maintaining standardized phytochemical quality, and minimizing environmental risks. Furthermore, it emphasizes the vital need for public awareness and rigorous pharmaceutical toxicity testing regarding stress-exposed herbal medicines, warning that stress-induced surges in secondary metabolites can elevate chemical concentrations to unsafe or toxic levels for consumers if established herbal monograph dosages and drug interaction guidelines are ignored.
Featured Image
Photo by Meiying Ng on Unsplash
Why is it important?
This article is important because it bridges environmental plant biology and pharmaceutical safety, demonstrating how environmental stresses like drought, cold, and salinity trigger secondary metabolite fluctuations in medicinal plants (such as Catharanthus roseus, Salvia officinalis, and Papaver somniferum) that can inadvertently raise chemical active ingredients to toxic levels for consumers. By emphasizing the need for strict adherence to herbal monographs, routine pharmaceutical toxicity testing, and advanced biotechnological conservation tools, the article provides a critical framework for protecting endangered plant species, standardizing natural drug safety and efficacy, and strategically managing environmental factors to safely optimize therapeutic yields.
Perspectives
Looking at future perspectives, the article outlines a threefold strategic horizon spanning industrial agriculture, regulatory safety, and biotechnological conservation: it envisions the industrial use of controlled abiotic stress (elicitation) to intentionally boost high-value secondary metabolites in crops, mandates heightened regulatory oversight and batch toxicity testing to account for stress-induced chemical surges before botanical products reach consumers, and advocates for advanced genomic and tissue-culture tools to protect endangered medicinal plant species from climate-driven extinction while standardizing their therapeutic profiles.
Dr Mayssaloune Ali Kanso
Beirut Arab University
Read the Original
This page is a summary of: MEDICINAL PLANTS’ STRESS FACTORS: EFFECTS ON METABOLITES AND NOVEL PERSPECTIVES FOR TOLERANCE, BAU Journal - Health and Wellbeing, October 2022, Beirut Arab University,
DOI: 10.54729/xwwg9154.
You can read the full text:
Contributors
The following have contributed to this page
